Skip to main content

Diagnosis of Osteosarcopenia – Clinical

  • Chapter
  • First Online:
Osteosarcopenia: Bone, Muscle and Fat Interactions
  • 527 Accesses

Abstract

Over the last two decades several authors have been demonstrating the existence of a wide and complex interaction between muscle and bone, which goes beyond mechanostatic action. Muscle performance as well as osteokines and myokines secreted by both bone and muscle, (respectively) and systemic hormones regulate the growth and performance of both tissues. The dysfunctional interaction between muscle and bone translates into clinical practice in a phenotype of greater risk for falls, physical functional loss and more fractures. In 2009, Binkley et al. call the attention to the individuals who would be the carriers of this phenotype, which would be identified by the association between low bone mass and low muscle mass, then referred to as “sarco-osteopenic or sarco-osteoporotic”. In the following years, the term “osteosarcopenia” arises as a way to encompass the two previous concepts. However, the difficulty in conceptualizing osteosarcopenia increased and, consequently, the variety of diagnostic criteria, which became one of the main challenges for the epidemiological studies and the clinical characterization of these patients. The clinical manifestations of osteosarcopenia include, in part, the same as those observed in subjects with isolated sarcopenia or osteoporosis, however, there are some characteristics that are more specific and that may help the clinician in the identification of these patients. It is important to note that osteosarcopenia is a clinical syndrome due to the physiological and functional deterioration of the musculoskeletal system, which is strongly related to the aging process and differs from isolated osteoporosis and sarcopenia, being associated with worse musculoskeletal outcomes. The other chapters of this book will describe the complexity of this syndrome, which is not limited to the mere association between sarcopenia and osteoporosis, but rather a phenotype of greater clinical vulnerability. In this chapter, we will discuss the most frequent and specific clinical manifestations, based on the compilation of several epidemiological studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Binkley N, Buehring B (2009) Beyond FRAX: it’s time to consider “sarco-osteopenia”. J Clin Densitom 12(4):413–416

    Article  PubMed  Google Scholar 

  • Brotto M, Johnson ML (2014) Endocrine crosstalk between muscle and bone. Curr Osteoporos Rep 12(2):135–141

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101

    Article  PubMed  Google Scholar 

  • Crepaldi G, Maggi S (2005) Sarcopenia and osteoporosis: a hazardous duet. J Endocrinol Investig 28(10 Suppl):66–68

    CAS  Google Scholar 

  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2019) Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31

    Article  PubMed  Google Scholar 

  • Curtis E, Litwic A, Cooper C, Dennison E (2015) Determinants of muscle and bone aging. J Cell Physiol 230(11):2618–2625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R, ATig F (2016) Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 28(5):895–899

    Article  PubMed  Google Scholar 

  • Edwards MH, Gregson CL, Patel HP et al (2013) Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study. J Bone Miner Res 28(11):2295–2304

    Article  PubMed  Google Scholar 

  • Frisoli A Jr (2017) Osteosarcopenia: a practical approach for the prevention of falls and osteoporotic fractures. In: WCO- IOF-ESCEO – world congress on osteoporosis, osteoarthristis and musculoskeletal diseases, 2017, Florence, Italy, Osteoporosis International

    Google Scholar 

  • Frisoli A Jr, Martin FG, Ingham S, Carvalho AC, Chaves P (2017) The association of osteosarcopenia, sarcopenia and osteoporosis with weakness and mobility in older adults with cardiovascular disease: data from sarcos study. In: WCO-IOF- ESCEO – world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, 2017, Florence, Italy, Osteoporosis International, v.28

    Google Scholar 

  • Frisoli A Jr, Chaves PH, Ingham SJ, Fried LP (2011) Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women’s Health and Aging Study (WHAS) II. Bone 48(4):952–957

    Article  PubMed  Google Scholar 

  • Gonzalez-Montalvo JI, Alarcon T, Gotor P et al (2016) Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 16(9):1021–1027

    Article  PubMed  Google Scholar 

  • Greeves JP, Cable NT, Reilly T, Kingsland C (1999) Changes in muscle strength in women following menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci (Lond) 97(1):79–84

    Article  CAS  Google Scholar 

  • Guralnik JM, Simonsick EM, Ferrucci L et al (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49(2):M85–M94

    Article  CAS  PubMed  Google Scholar 

  • Hassan EB, Duque G (2017) Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician 46(11):849–853

    PubMed  Google Scholar 

  • Hida T, Ishiguro N, Shimokata H et al (2013) High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 13(2):413–420

    Article  PubMed  Google Scholar 

  • Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA (2002) Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 76:473–481

    Article  CAS  PubMed  Google Scholar 

  • Huo YR, Suriyaarachchi P, Gomez F et al (2015) Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc 16(4):290–295

    Article  PubMed  Google Scholar 

  • Huo YR, Suriyaarachchi P, Gomez F et al (2016) Phenotype of sarcopenic obesity in older individuals with a history of falling. Arch Gerontol Geriatr 65:255–259

    Article  PubMed  Google Scholar 

  • Laurent MR, Dubois V, Claessens F et al (2016) Muscle-bone interactions: from experimental models to the clinic? A critical update. Mol Cell Endocrinol 432:14–36

    Article  CAS  PubMed  Google Scholar 

  • Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age- associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860

    Article  PubMed  Google Scholar 

  • Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC (1993) Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) 84(1):95–98

    Article  CAS  Google Scholar 

  • Tagliaferri C, Wittrant Y, Davicco MJ, Walrand S, Coxam V (2015) Muscle and bone, two interconnected tissues. Ageing Res Rev 21:55–70

    Article  CAS  PubMed  Google Scholar 

  • Wang YJ, Wang Y, Zhan JK, Tang ZY, He JY, Tan P, Deng HQ, Huang W, Liu YS (2015) Sarco -osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol 2015:482940

    PubMed  PubMed Central  Google Scholar 

  • World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, vol 843. WHO Technical Report Series, Geneve

    Google Scholar 

  • Yoo JI, Kim H, Ha YC, Kwon HB, Koo KH (2018) Osteosarcopenia in patients with hip fracture is related with high mortality. J Korean Med Sci 33(4):e27

    Article  PubMed  Google Scholar 

  • Yoshimura N, Muraki S, Oka H et al (2017) Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int 28(1):189–199

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Frisoli, A. (2019). Diagnosis of Osteosarcopenia – Clinical. In: Duque, G. (eds) Osteosarcopenia: Bone, Muscle and Fat Interactions. Springer, Cham. https://doi.org/10.1007/978-3-030-25890-0_11

Download citation

Publish with us

Policies and ethics